Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
The plant milking technology is capable of producing high value active pharmaceutical compounds More
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
Long standing experienced South American Laboratory is seeking to expand its distribution of prescription products into Nigeria, Kenya and Angola. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2008 - 120 pages - $1,040
Jan 2010 - $15,200
Jan 2009 - $15,200
Sep 2010 - 412 pages - $1,040
Nov 2010 - 7 pages - $500
Apr 2009 - 450 pages - $3,490
May 2011 - 23 pages - $125
Mar 2011 - 6 pages - $500
Nov 2010 - 27 pages - $99
Apr 2010 - 17 pages - $99
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us